Clinical Trials · NCT01343004
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Radius Health, Inc.
- Enrollment
- 2,463
- Start date
- Apr 2011
- Locations
- 28 sites, 10 countries
- Primary endpoint
- Number of Participants With New Vertebral Fractures at 18 Months